A novel method to produce armored double-stranded DNA by encapsulation of MS2 viral capsids

Verfasser / Beitragende:
[Lei Zhang, Yu Sun, Le Chang, Tingting Jia, Guojing Wang, Rui Zhang, Kuo Zhang, Jinming Li]
Ort, Verlag, Jahr:
2015
Enthalten in:
Applied Microbiology and Biotechnology, 99/17(2015-09-01), 7047-7057
Format:
Artikel (online)
ID: 60550282X
LEADER caa a22 4500
001 60550282X
003 CHVBK
005 20210128100607.0
007 cr unu---uuuuu
008 210128e20150901xx s 000 0 eng
024 7 0 |a 10.1007/s00253-015-6664-4  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s00253-015-6664-4 
245 0 2 |a A novel method to produce armored double-stranded DNA by encapsulation of MS2 viral capsids  |h [Elektronische Daten]  |c [Lei Zhang, Yu Sun, Le Chang, Tingting Jia, Guojing Wang, Rui Zhang, Kuo Zhang, Jinming Li] 
520 3 |a With the rapid development of molecular diagnostic techniques, there is a growing need for quality controls and standards with favorable properties to monitor the entire detection process. In this study, we describe a novel method to produce armored hepatitis B virus (HBV) and human papillomavirus (HPV) DNA for use in nucleic acid tests, which was confirmed to be stable, homogeneous, noninfectious, nuclease resistant, and safe for shipping. We demonstrated that MS2 bacteriophage could successfully package double-stranded DNA of 1.3-, 3-, 3.5-, and 6.5-kb length into viral capsids with high reassembly efficiency. This is the first application of RNA bacteriophage MS2 as a platform to encapsulate double-stranded DNA, forming virus-like particles (VLPs) which were indistinguishable from native MS2 capsids in size and morphology. Moreover, by analyzing the interaction mechanism of pac site and the MS2 coat protein (CP), we found that in addition to the recognized initiation signal TR-RNA, TR-DNA can also trigger spontaneous reassembly of CP dimers, providing a more convenient and feasible method of assembly. In conclusion, this straightforward and reliable manufacturing approach makes armored DNA an ideal control and standard for use in clinical laboratory tests and diagnostics, possessing prospects for broad application, especially providing a new platform for the production of quality controls for DNA viruses. 
540 |a Springer-Verlag Berlin Heidelberg, 2015 
690 7 |a Armored double-stranded DNA  |2 nationallicence 
690 7 |a MS2 bacteriophage  |2 nationallicence 
690 7 |a Encapsulation  |2 nationallicence 
690 7 |a Virus-like particles  |2 nationallicence 
690 7 |a Quality controls  |2 nationallicence 
700 1 |a Zhang  |D Lei  |u Peking University Fifth School of Clinical Medicine, Beijing, People's Republic of China  |4 aut 
700 1 |a Sun  |D Yu  |u National Center for Clinical Laboratories, Beijing Hospital, Beijing, People's Republic of China  |4 aut 
700 1 |a Chang  |D Le  |u National Center for Clinical Laboratories, Beijing Hospital, Beijing, People's Republic of China  |4 aut 
700 1 |a Jia  |D Tingting  |u National Center for Clinical Laboratories, Beijing Hospital, Beijing, People's Republic of China  |4 aut 
700 1 |a Wang  |D Guojing  |u National Center for Clinical Laboratories, Beijing Hospital, Beijing, People's Republic of China  |4 aut 
700 1 |a Zhang  |D Rui  |u National Center for Clinical Laboratories, Beijing Hospital, Beijing, People's Republic of China  |4 aut 
700 1 |a Zhang  |D Kuo  |u National Center for Clinical Laboratories, Beijing Hospital, Beijing, People's Republic of China  |4 aut 
700 1 |a Li  |D Jinming  |u Peking University Fifth School of Clinical Medicine, Beijing, People's Republic of China  |4 aut 
773 0 |t Applied Microbiology and Biotechnology  |d Springer Berlin Heidelberg  |g 99/17(2015-09-01), 7047-7057  |x 0175-7598  |q 99:17<7047  |1 2015  |2 99  |o 253 
856 4 0 |u https://doi.org/10.1007/s00253-015-6664-4  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s00253-015-6664-4  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Zhang  |D Lei  |u Peking University Fifth School of Clinical Medicine, Beijing, People's Republic of China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Sun  |D Yu  |u National Center for Clinical Laboratories, Beijing Hospital, Beijing, People's Republic of China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Chang  |D Le  |u National Center for Clinical Laboratories, Beijing Hospital, Beijing, People's Republic of China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Jia  |D Tingting  |u National Center for Clinical Laboratories, Beijing Hospital, Beijing, People's Republic of China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Wang  |D Guojing  |u National Center for Clinical Laboratories, Beijing Hospital, Beijing, People's Republic of China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Zhang  |D Rui  |u National Center for Clinical Laboratories, Beijing Hospital, Beijing, People's Republic of China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Zhang  |D Kuo  |u National Center for Clinical Laboratories, Beijing Hospital, Beijing, People's Republic of China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Li  |D Jinming  |u Peking University Fifth School of Clinical Medicine, Beijing, People's Republic of China  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Applied Microbiology and Biotechnology  |d Springer Berlin Heidelberg  |g 99/17(2015-09-01), 7047-7057  |x 0175-7598  |q 99:17<7047  |1 2015  |2 99  |o 253